Viewing Study NCT01623167


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-05-27 @ 11:43 AM
Study NCT ID: NCT01623167
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-11
First Post: 2012-06-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Aplastic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pancytopenia View
None Immunosuppression View
None Hematopoesis View
None Autoimmunity View
None Thrombocytopenia View